Valuation : Repligen Corporation

Market Cap 10.27B 8.82B 8.26B 7.56B 14.24B 981B 14.28B 97.76B 38.22B 494B 38.57B 37.74B 1,637B P/E 2026 *
241x
P/E 2027 * 105x
Enterprise Value 10.04B 8.62B 8.07B 7.39B 13.92B 959B 13.96B 95.54B 37.35B 483B 37.69B 36.88B 1,599B EV / Sales 2026 *
12.1x
EV / Sales 2027 * 10.2x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 day-2.71%
1 week-1.51%
Current month+26.51%
1 month+22.74%
3 months+45.35%
6 months+42.75%
Current year+8.87%
1 week 176.28
Extreme 176.28
185.34
1 month 139.4
Extreme 139.3975
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
8/20/26 Fiscal year

Chief Executive Officer

16,278 0.0288%
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%-1.51%+46.02%+7.39% 10.27B
+0.73%-3.81%-14.59%+9.15% 193B
+1.56%-2.34%-0.86%+12.02% 115B
+0.30%+1.39%+11.24%+78.77% 61.3B
-0.25%-3.31%+27.04%+55.45% 51.37B
+0.79%-1.34%-0.95%-32.72% 51.24B
+1.22%-2.00%+20.53%-8.86% 33.69B
+2.03%+2.86% - - 30.4B
-1.64%-3.58%+38.70%-15.60% 24.36B
-0.82%-1.46%-5.14%+22.13% 23.7B
Average +0.12%-0.06%+13.55%+14.19% 59.46B
Weighted average by Cap. +0.65%-1.02%+1.95%+16.08%

Financials

2026 *2027 *
Net sales 827M 710M 665M 609M 1.15B 78.99B 1.15B 7.87B 3.08B 39.81B 3.11B 3.04B 132B 969M 832M 779M 713M 1.34B 92.57B 1.35B 9.22B 3.61B 46.65B 3.64B 3.56B 154B
Net income 41.92M 35.99M 33.69M 30.85M 58.12M 4B 58.28M 399M 156M 2.02B 157M 154M 6.68B 98.84M 84.84M 79.43M 72.74M 137M 9.44B 137M 941M 368M 4.76B 371M 363M 15.75B
Net Debt -234M -201M -188M -172M -324M -22.32B -325M -2.22B -869M -11.25B -877M -858M -37.22B -407M -350M -327M -300M -565M -38.9B -566M -3.88B -1.52B -19.61B -1.53B -1.5B -64.89B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-28 $177.47 -2.51% 191,939
26-08-27 $182.03 +0.96% 611,896
26-08-26 $180.30 -0.77% 539,095
26-08-25 $181.69 +0.04% 1,142,346
26-08-24 $181.62 +0.27% 1,497,952
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
182.03USD
Average target price
185.70USD
Spread / Average Target
+2.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock